Access cutting-edge glycogen storage disease type ii (gsd-ii) treatment through this clinical trial at a research site in Grand Rapids. Study-provided care at no cost to qualified participants.
Quick Self-Assessment
See if you qualify for this Grand Rapids location
Preparing your pre-screening questions…
Access glycogen storage disease type ii (gsd-ii) specialists at no cost
This study follows strict safety protocols and ethical guidelines
All study-related glycogen storage disease type ii (gsd-ii) treatment provided free
Check if you qualify for this glycogen storage disease type ii (gsd-ii) clinical trial in Grand Rapids, MI
No-Cost Study Care
Local to Grand Rapids
Convenient for MI residents
Cutting-Edge Treatment
Access to innovative therapies
Expert Medical Care
Close monitoring by specialists
Possible Compensation*
For time and travel
*Compensation varies by study. Confirm details with coordinator.
This Sub-registry is a multicenter, international, longitudinal, observational, and voluntary program designed to track pregnancy outcomes for any pregnant woman enrolled in the Pompe Registry, regardless of whether she is receiving disease-specific therapy (such as ERT with alglucosidase alfa or avalglucosidase alfa) and irrespective of the commercial product with which she may be treated. No experimental intervention is given; thus a patient will undergo clinical assessments and receive standard of care treatment as determined by the patient's physician. The primary objective of this Sub-registry is to track pregnancy outcomes, including complications and infant growth, in all women with Pompe disease during pregnancy, regardless of whether they receive disease-specific therapy, such as ERT with alglucosidase alfa or avalglucosidase alfa.
Sponsor: Genzyme, a Sanofi Company
Yes, this clinical trial (NCT00567073) has an active research site in Grand Rapids, MI that is currently enrolling participants.
Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.
Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.
Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.
If you're searching for glycogen storage disease type ii (gsd-ii) treatment options in Grand Rapids, MI, this clinical trial (NCT00567073) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Grand Rapids research site is actively enrolling participants for this clinical trial. You'll receive care from experienced glycogen storage disease type ii (gsd-ii) specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.
Looking for more options? Browse all glycogen storage disease type ii (gsd-ii) clinical trials near you to find additional studies recruiting in your area.
See all pulmonary embolism clinical trials recruiting in Grand Rapids — not just this study.
Browse Pulmonary Embolism Trials in Grand Rapids →